Created in 1999 (United States), REPLAGAL own 440 sister brands and 4958 competing brands. The REPLAGAL brand is owned by Takeda Pharmaceutical, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is JP3463000004. REPLAGAL belongs to the Drug Manufacturers business sector.